| Maranda Ransdell, LCSW | |
|
975 Kirman Ave, Reno, NV 89502-0993 | |
| (775) 786-7200 | |
| (775) 337-2208 |
| Full Name | Maranda Ransdell |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 975 Kirman Ave, Reno, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396284808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6538-C (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maranda Ransdell, LCSW 975 Kirman Ave, Reno, NV 89502-0993 Ph: (775) 786-7200 | Maranda Ransdell, LCSW 975 Kirman Ave, Reno, NV 89502-0993 Ph: (775) 786-7200 |
News Archive
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease. The study builds on past research and shows that studies performed on mice are more likely to translate to humans than previously thought.
Physicists and neuroscientists from The University of Nottingham and University of Birmingham have unlocked one of the mysteries of the human brain, thanks to new research using functional Magnetic Resonance Imaging (fMRI) and electroencephalography (EEG).
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
Idenix Pharmaceuticals, Inc, a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that the Company will receive a payment of $20 million from the ViiV Healthcare Company for the achievement of a clinical milestone relating to GSK2248761.
› Verified 8 days ago
Amanda Nielsen, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 495 Apple St Ste 100, Reno, NV 89502 Phone: 775-525-0270 Fax: 775-432-6150 | |
Mrs. Erin Snell, LCSW, MBA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 85 Kirman Ave Ste 200, Reno, NV 89502 Phone: 775-982-2862 Fax: 775-982-2865 | |
Kayci Itza, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 850 Mill St Ste 100, Reno, NV 89502 Phone: 775-374-0335 | |
Brianna Michelle Villalpando, LCSWI Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 85 Kirman Ave, Reno, NV 89502 Phone: 775-982-2862 | |
Sandie W Fox, LCSW, LCADC Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 505 S Arlington Ave, Ste 212a, Reno, NV 89509 Phone: 775-544-5650 Fax: 775-870-1310 | |
Ms. Joanne Ussher, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 745 W Moana Ln Ste 100, Reno, NV 89509 Phone: 775-334-3033 Fax: 775-284-1305 | |
Caroline Cova, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 975 Kirman Ave, Reno, NV 89502 Phone: 775-342-6600 Fax: 775-324-6605 |